Predictiors of recovery in patients with schizophrenia study
Not Applicable
- Conditions
- Schizophrenia
- Registration Number
- JPRN-UMIN000014852
- Lead Sponsor
- The Jikei University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
- patient(s) who can not understand informed consent document - comorbidity of substance related disorders - severe physical disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Discovery of developmental, psychological, and social factors as predictors for recovery and remission in patients with schizophrenia
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie functional recovery in schizophrenia patients according to the PREPS study?
How do novel antipsychotic interventions compare to standard-of-care in functional recovery for schizophrenia?
Which genetic or neuroimaging biomarkers predict treatment response in schizophrenia recovery studies?
What adverse events are associated with antipsychotic therapies in schizophrenia trials and how are they managed?
What combination therapies show efficacy in schizophrenia recovery beyond standard antipsychotics?